Preclinical Characterization of 3β-(N-Acetyl l-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer.
| Image |  |
|---|---|
| Description | scientific article published on 25 April 2016 |
| Author/s |
author: Giacomo Canesin Susan Evans-Axelsson |
| Publication date | May 3, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |